Earnings Call · Q3 FY2023·2023-11-06

Q3 23EPS +2.77%·Rev n/aQ2 23EPS +0.26%·Rev n/aQ1 23EPS +1.67%·Rev n/aQ4 22EPS +7.12%·Rev n/a⚠ consensus missing

VERTEX PHARMACEUTICALS INC / MA VRTX

Susie Lisa — Senior Vice President, Investor Relations

Reshma Kewalramani — Chief Executive Officer and President

Stuart Arbuckle — Chief Operating Officer

Charlie Wagner — Chief Financial Officer

−1.9%1d on move date−2.2% vs SPY3d−4.5%5d−1.8%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more VRTX calls or request research access.

More VRTX calls Browse calls Request research access